M

Mayflower

North America, Massachusetts, United States, Boston

Description

Venture Capital Firm

Investor Profile

Mayflower has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series Unknown (33%)

Country Focus

  • United States (33%)
  • Germany (33%)
  • China (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Hospital
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Wellness
  • Quality Assurance
  • Saas
  • Search Engine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mayflower frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 1
TC
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 1
Nexus Medical Partners
North America, Massachusetts, United States, Quincy
Co-Investments: 1
Pound Capital
North America, Connecticut, United States, Stamford
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alpha Associates
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Mayflower?

Ryte

München, Bayern, Germany

Ryte is a SaaS company that provides software to digital marketers, agencies, and freelancers.

Quality AssuranceSaaSSearch EngineSoftware
Series AJan 11, 2021
Amount Raised: $10,336,005
IXX.com

Beijing, Beijing, China

IXX.com is a digital currency exchange, the world's first pan-transaction eco-platform for business.

BlockchainCryptocurrencyFinTech
Series UnknownJun 19, 2019
Amount Raised: $5,000,000
Neurotech

Lincoln, Rhode Island, United States

Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.

BiotechnologyHealth CareHospitalMedicalPharmaceuticalTherapeuticsWellness
Series BNov 16, 2006
Amount Raised: $35,000,000